Braveheart Bio (BRVE) director Agarwala details 10.23M shares held via AH Bio Fund
Rhea-AI Filing Summary
Braveheart Bio, Inc. director Vineeta Agarwala reported initial ownership on a Form 3. The filing shows 10,232,420 shares of Common Stock held indirectly through AH Bio Fund IV, L.P., which also acts as nominee for several affiliated funds. AH Equity Partners Bio IV, L.L.C. is the general partner of AH Bio Fund IV and has sole voting and dispositive power over these securities. Agarwala is a member of AH Equity Partners Bio IV but disclaims beneficial ownership of the securities held by AH Bio Fund IV, except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Agarwala Vineeta
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock F1, F2 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 10,232,420 shares (Indirect, By AH Bio Fund IV, L.P.)
Footnotes (2)
- F1. The reported securities are held by AH Bio Fund IV, L.P. ("AH Bio Fund IV"), for itself and as nominee for AH Bio Fund IV-B, L.P., AH 2022 Annual Fund, L.P., AH 2022 Annual Fund-B, L.P., AH 2022 Annual Fund-QC, L.P. and CLF Partners III, LP. AH Equity Partners Bio IV, L.L.C. ("AH EP Bio IV") is the general partner of AH Bio Fund IV and has sole voting and dispositive power with regard to the securities held by AH Bio Fund IV for itself and as nominee. The managing members of AH EP Bio IV are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to share voting and dispositive power with respect to the securities held by AH Bio Fund IV for itself and as nominee.
- F2. The Reporting Person serves as one of the members of AH EP Bio IV, but she disclaims the existence of a "group" (as that term is used in Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), and disclaims beneficial ownership of the securities directly held by AH Bio Fund IV, and this report shall not be deemed an admission that she is the beneficial owner of the securities reported herein for purposes of Section 16 of the Exchange Act, or for any other purpose, except to the extent of her pecuniary interest therein, if any.
Key Figures
Indirectly held Common Stock: 10,232,420 shares
Security title: Common Stock
Form type: Form 3
3 metrics
Indirectly held Common Stock
10,232,420 shares
Common Stock indirectly owned through AH Bio Fund IV, L.P.
Security title
Common Stock
Class of securities reported as indirectly owned
Form type
Form 3
Initial statement of beneficial ownership filed by director
Key Terms
beneficial ownership, pecuniary interest, dispositive power, voting power, +1 more
5 terms
beneficial ownership regulatory
"she disclaims beneficial ownership of the securities directly held by AH Bio Fund IV"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of her pecuniary interest therein, if any"
dispositive power financial
"has sole voting and dispositive power with regard to the securities held"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
voting power financial
"has sole voting and dispositive power with regard to the securities held"
Voting power is the ability shareholders have to influence a company's major decisions—like electing the board, approving mergers, or changing corporate rules—based on the voting rights attached to the shares they hold. For investors it matters because greater voting power is like holding more keys to a building: it gives you a stronger say over management choices and the company’s strategy, which can affect future value and risk.
indirect ownership financial
"The reported securities are held by AH Bio Fund IV, L.P."
FAQ
What did Braveheart Bio (BRVE) director Vineeta Agarwala report on this Form 3?
Vineeta Agarwala reported indirect ownership of 10,232,420 shares of Common Stock of Braveheart Bio, Inc., held through AH Bio Fund IV, L.P. and related investment funds, as of the Form 3 reporting date.
What is AH Equity Partners Bio IV, L.L.C.’s role in the BRVE holdings?
AH Equity Partners Bio IV, L.L.C. is the general partner of AH Bio Fund IV and has sole voting and dispositive power over the Braveheart Bio shares held by AH Bio Fund IV for itself and as nominee for affiliated funds.
AI-generated analysis. How Rhea-AI works. Not financial advice.
